Effects of acute and repeated administration of a cholinesterase inhibitor on timing behaviour.
It has been hypothesised that a leftward shift in the response distribution obtained in the peak interval (PI) procedure is a characteristic of cognitive enhancement in which mental processes are speeded. Metrifonate, a cholinesterase inhibitor with reported cognitive enhancing properties in many animal models of learning and memory, was tested in the PI procedure. Acute administration of 3 and 60 mg/kg but not 1 and 30 mg/kg in fully trained rats shifted the response distribution to the right, whereas subchronic administration of 10, 30 or 50 mg/kg during task acquisition had no effect on timing behaviour. On the basis of the present data, it can be concluded that the effects of a cognition enhancer in the PI procedure cannot be predicted from the scalar expectancy theory (SET). Furthermore, SET does not appear to be an appropriate tool for analysing the acquisition of timing behaviour.
Bouger
Pascale C
PC
CNS Research, Bayer AG, Aprather Weg 18a, D-42096 Wuppertal, Germany.
Spowart-Manning
Laura
L
Ferrara
Andre
A
Schmidt
Bernard H
BH
van der Staay
Franz-Josef
FJ
D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004192:Discrimination, Psychological / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D008297:Male; D008606:Mental Processes / Q000187:drug effects*; D008960:Models, Psychological; D051381:Rats; D013998:Time Perception / Q000187:drug effects*; D014236:Trichlorfon / Q000494:pharmacology*
D002800:Cholinesterase Inhibitors; D014236:Trichlorfon